Trxade Group Inc. MEDS Archives - Page 7 of 9

TuesdayApr 28, 2020 1:24 pm

QualityStocksNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Announces Engagement of MZ Group to Expand Strategic Communications Program Across Key Markets

Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, today announced its engagement of international investor relations specialists MZ Group (“MZ”) to expand its comprehensive strategic investor relations and financial communications program across all key markets. According to the update, MZ Group will work closely with Trxade Group management in the development and implementation of a comprehensive capital markets strategy designed to increase the Company's visibility throughout the investment community. "This is an exciting time for Trxade Group, having achieved key growth milestones in 2019, positioning us for a breakout year in 2020 as we continue…

MondayApr 27, 2020 10:51 am

QualityStocksNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Enters First Agreement to Supply COVID-19 Testing Kits

Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, today announced entry into its first Covid-19 antibody testing kits supply agreement with law firm McIntyre Thanasides Bringgold Elliott Grimaldi Guito & Matthews, P.A. According to the update, the midsized Tampa firm will today begin periodic testing of its employees and their families, and the partnership will promote a safer working environment and increase Covid-19 exposure risk awareness. Trxade's Integra Pharma Solutions, LLC subsidiary will provide antibody rapid blood test kits, intended to be administered at point of care with no additional instrumentation needed, and Accomplished Home…

FridayApr 17, 2020 2:55 pm

QualityStocksNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Subsidiary Enabling Patients to Access Physicians from Home

Trxade Group’s (NASDAQ: MEDS) wholly owned subsidiary Bonum Health is a virtual telehealth provider that is helping patients to simply and affordably access board-certified physicians and receive medical prescriptions from the comfort of their homes. A recent article discussing the company reads, “On March 4, 2020, Congress approved an $8.3 billion package (http://ibn.fm/G8r6e) in emergency aid to combat the novel coronavirus, which included provisions for Medicare providers to administer telehealth services so that elderly patients, a particularly vulnerable demographic, could receive care at home. The aid package was summarily followed by a coalition of private health insurers, who after a…

MondayApr 13, 2020 10:44 am

Trxade Group Inc.’s (NASDAQ: MEDS) E-Commerce Platform Targeting Independent Pharmacy Market of Over $78 Billion a Year

Company boasts significant first-mover advantage in proprietary web-based e-commerce platform segment Revenue growth driven by increases in the number of registered users and acquisition of Pharmacy Currently adding 100+ pharmacies per month to its online purchasing platform Trxade seeking FDA approval for antibody rapid test that can be used for COVID-19 patients Trxade Group Inc. (NASDAQ: MEDS) is an integrated drug delivery, procurement, and health care platform that offers health care buyers and sellers of pharmaceuticals increased profit margins. The company has developed a proprietary web-based e-commerce platform (S2P – Supplier to Pharmacy) designed to help pharmacies reduce expenses by…

ThursdayApr 09, 2020 11:22 am

QualityStocksNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Reaches Thousands of Independent Pharmacies with e-Commerce Platform

Trxade Group (NASDAQ: MEDS), an integrated drug-procurement, delivery and healthcare platform that enables price transparency and increased profit margins to healthcare buyers and sellers of pharmaceuticals, has more than 12,100 pharmacies currently registered as users of its proprietary Supplier-to-Pharmacy (“S2P”) e-commerce platform. An article discussing the company reads, “With the current number of users already on the network — serving an estimated 12 to 15 million patients indirectly through these member pharmacies, and adding about 100 new pharmacies per month — Trxade’s goal is to reach most, if not all, of the 24,000 independent pharmacies in the United States, which…

WednesdayApr 08, 2020 1:22 pm

Trxade Group Inc. (NASDAQ: MEDS) Reports Revenue Growth Amid Buildup to Multi-Platform Telehealth Integration

Trxade Group Inc. is an expanding healthcare tech platform builder that aims to assist small, community-based pharmaceutical businesses and the patients who comprise their customers through drug pricing and delivery operations as well as telemedicine consultations Trxade Group recently announced its year-end financial statement for 2019, noting revenues had grown nearly double over the previous year, from $3.83 million to $7.43 million The company is celebrating a decade in operation with four platforms that are integrated synergistically to serve the needs of rural and neighborhood-centric health businesses on a subscription basis Trxade’s telehealth services enable patients to access licensed medical…

FridayApr 03, 2020 9:38 am

QualityStocksNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) to Hold 2020 Annual Meeting of Stockholders on May 29

Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, on Thursday announced that it will be holding its 2020 Annual Meeting of Stockholders at its corporate offices in Land O’ Lakes, Florida on Friday, May 29, 2020 at 10 AM local time. The record date for determination of stockholders authorized to vote at the meeting is set on or around the close of business on April 13, 2020. Additional information regarding the meeting will be disclosed in the company’s proxy statement which it plans to file with the Securities and Exchange Commission (“SEC”) following the record date.…

ThursdayApr 02, 2020 11:33 am

Trxade Group Inc. (NASDAQ: MEDS) Subsidiary Bonum Health Offers Key Technology in Fight Against Coronavirus

Trxade Group’s wholly owned subsidiary, Bonum Health, allows patients to access medical advice from the comfort of their homes Telemedicine is getting its moment in the clinical spotlight as COVID-19 contagion fears are being addressed by limiting face-to-face human interaction Congress has recently approved an $8.3 billion package which includes provisions for Medicare providers to provide telehealth services to their patients With large swathes of the population increasingly concerned about leaving their homes and medical practitioners swamped amidst the ongoing viral crisis, telemedicine is getting its moment in the clinical spotlight. Bonum Health (http://ibn.fm/yvrNY), the wholly owned subsidiary of Trxade Group…

WednesdayApr 01, 2020 10:10 am

QualityStocksNewsBreaks – Trxade Group, Inc.’s (NASDAQ: MEDS) Integra Pharma Solutions Files for FDA Emergency Use Authorization for Rapid COVID-19 Test Kit

Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, today announced that its wholly-owned subsidiary, Integra Pharma Solutions, has filed for an Emergency Use Authorization (“EUA”) with the U.S. Food and Drug Administration (“FDA”) in collaboration with its partnered manufacturer of the SARS-CoV-2 IgM/IgG Antibody Rapid Test Kit. Under section 564 of the Federal Food, Drug, and Cosmetic Act (FD&C Act), the FDA Commissioner may, in an emergency, allow unapproved medical products or unapproved uses of approved medical products to be used in the diagnosis, treatment or prevention of serious or life-threatening diseases or when there…

MondayMar 30, 2020 11:32 am

QualityStocksNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Announces 2019 Annual Results

Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform that enables price transparency and increased profit margins to healthcare buyers and sellers of pharmaceuticals, today announced annual results for the year ended December 31, 2019. According to the update, the company reported $7.43 million in revenues from continuing operations compared to $3.83 million for 2018, as well as $125,244 in operating income for the year 2019 compared to an operating loss of ($87,616) in 2018. “In addition to increased revenue growth from our companies, Trxade Group achieved a number of significant milestones around innovation and enhancements…

Site Search

Company Search

Tag: Trxade Group Inc. MEDS